A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia

Phase 2 Completed 80 enrolled Charsire Biotechnology Corp.

RandomizedParallel-groupTriple-blindTreatment

Summary

A Randomized, Double-Blind, Vehicle-Controlled, Parallel, Phase II Study to Evaluate Efficacy and Safety of BAC in Patient with Alzheimer's Disease or Vascular Dementia

Timeline

Start: 2016-12
Primary completion: 2018-11-01
Completion: 2018-11-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	BAC	Unknown	30 g	Topical

A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia

Summary

Timeline

Drugs

Indications